Bio Protocol vs Neutron — how do they compare? Bio Protocol trades at Rp514.29 (market cap Rp1,16T, Rp252,63M 24h volume), while Neutron trades at Rp25.52 (market cap Rp78,1M, Rp76,5M 24h volume). The key difference: Bio Protocol is far larger — about 14852.8× Neutron's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 804,1M / 999,7M NTRN (81%) for Neutron. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Neutron for 37 Days on average.
| BIO | NTRN | |
|---|---|---|
Market Cap | Rp1,16T | Rp78,1M |
Volume (24h) | Rp252,63M | Rp76,5M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 804,1M / 999,7M NTRN (81%) |
Typical Hold Time | 16 Days | 37 Days |
What Pluang investors did over the last 30 days
No sentiment data available yet.
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Neutron is the most secure cross-chain smart-contracting platform. It combines the security of a top 10 blockchain by staked capitalization with bleeding-edge cross-chain infrastructure to enable DeFi applications to securely scale across a growing network of 51+ interconnected blockchains.
Read more on NTRN →